Adicet Bio Stock Discussion

$Adicet Bio(ACET.US)$ Adicet Bio Highlights Preclinical Data Supporting Ind Readiness for Adi-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (Asgct) 27TH Annual Meeting.              Preclinical Findings Showed Robust Anti-Tumor Activity of Adi-270 in Multiple Cd70-Positive Solid and Hematological Cancer Models

$Adicet Bio(ACET.US)$ Adicet Bio On Track to File IND for ADI-270 in Renal Cell Carcinoma in 2Q >ACET
Dow Jones· 5 mins ago

$Adicet Bio(ACET.US)$ Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
7 MINUTES AGO, 4:01 PM EST
VIA BUSINESSWIRE

$Adicet Bio(ACET.US)$
Analysts monitoring Adicet Bio come to a price target consensus of $14.75

$Adicet Bio(ACET.US)$ 🤔

follow for daily watchlist ⭐️
$Applied Optoelectronics(AAOI.US)$ $Adicet Bio(ACET.US)$ $AC Immune(ACIU.US)$ $Applied Digital(APLD.US)$ $AST SpaceMobile(ASTS.US)$ $AeroVironment(AVAV.US)$ $AstraZeneca(AZN.US)$ $Campbell Soup(CPB.US)$ $Generac(GNRC.US)$ $Leap Therapeutics(LPTX.US)$ $McCormick & Co(MKC.US)$ $Regeneron Pharmaceuticals(REGN.US)$ $Lordstown Motors(RIDE.US)$ $Theriva Biologics(TOVX.US)$ $Walgreens Boots Alliance(WBA.US)$